Tools to Address Adherence Issues in Patients With SIHD

Slides:



Advertisements
Similar presentations
Section 2.6 Question 1. Section 2.6 Answer 1 Section 2.6 Question 2.
Advertisements

Education & Training Curriculum on Multiple Chronic Conditions (MCC) Strategies & tools to support healthcare professionals caring for people living with.
CMS National Conference on Care Transitions December 3,
© The Johns Hopkins University and The Johns Hopkins Health System Corporation, 2011 Teamwork Data Armstrong Institute for Patient Safety and Quality Presented.
Symptom Control and Enhancing Functioning in Schizophrenia
John Peter Smith FMRP, Fort Worth, Texas
LEADERS IN HEALTH PROFESSIONAL EDUCATION.
HIV and the ART of Prevention
PCSK9 Inhibitors Post-CVOTs
Duration of Dual Antiplatelet Therapy Post-ACS: Lessons From Clinical Trials.
Program Themes. Consulting on Common Concerns in PAH: How Would You Manage These Patients?
RESISTANT HYPERTENSION OR POOR PATIENT ADHERENCE? TIPS TO GAIN CONTROL
Improving the Diagnosis and Treatment of Seizures in Long-term Care
HIV Testing:.
The Burden of Hospital-Associated Venous Thromboembolism
Overview of Disparities
Does One Size Fit All in Obesity Management?
UNDERSTANDING RISK STRATIFICATION IN PAH:
The Nurse View.
Patient Case Discussions in T2D: What Intensification Plan Is Best?
Duration of Dual Antiplatelet Therapy Post-ACS: Lessons from Clinical Trials.
Medication Nonadherence in Gout
Improving Acne Outcomes
Patient-Centered Care in Cystic Fibrosis
How to Achieve Aggressive BP Goals in Difficult-to-Treat Patients
Optimizing Outcomes in the Management of GIST
Introduction. Risk Communication With Patients: Your Guide to Resources and Recommendations.
What Do We Know About LDL-C?
Strategies to Improve Adherence and Persistence in the Treatment of Hypertension.
How and When to Decide on Revascularization in Stable Ischemic Heart Disease.
Goals. Achieving HbA1c Goals: Applying Guidelines to Intensify Therapy in Patients With Diabetes.
Panelists. One Size May Not Fit All: A New Aspirin Option for the High-Risk Patient.
Blood pressure control: dependence on adherence
Talking to Patients About Diabetes Management
Clinical Updates in RA: New Developments and Insights From Washington
Case Study. Managing Medication and Adherence in SIHD: Partnering With the Patient to Improve Care.
From Symptom Management to Communication in Advanced GI Cancers
This program will include a discussion of off-label treatment and investigational agents not approved by the FDA for use in the US, and data that were.
Early and Intensive T2D Management:
Managing Depression is a Team Effort:
Avoiding Opioid Overuse: Guideline-Based Management of Osteoarthritis
CV Risk Management in T2DM: What Did We Learn from ADA 2016?
Improving Therapeutic Management of Huntington's Disease in Long-Term Care.
The Importance of Getting the Dose Right in HF
Updated Guideline Recommendations for the Definitive Diagnosis of Unexplained Syncope.
Oral Prostanoids and PAH
Program Goals Overview Is NEDA a Reasonable Target?
Duration of Dual Antiplatelet Therapy Post-ACS: Lessons from Clinical Trials.
The Road to Quality Improvement in HER2-Positive Breast Cancer
Pharmacotherapy for Diabetic Coronary Disease:
Managing Age-Related Clinical Issues in Hemophilia
Addressing Pneumococcal Disease in Latino Communities
Current Challenges in Managing Hemophilia
Iron Deficiency in Heart Failure
A Nursing Perspective on Improving Outcomes for Patients With Hemophilia.
The Rising Crisis of Prediabetes Diagnosis and Management of the Patient With Prediabetes.
Improving Adherence to Antiplatelet Therapy After an ACS Event
Inhaled Antibiotics for Patients With CF in the Era of CFTR Modulators
Practical Tools for SCA Screening
2015 EASD In Review: CV Risk management in t2dm
Strategies for Infection Control in Cystic Fibrosis
Copyright. Approaches to Population Health in 2015: A National Survey of Hospitals.
Our Community Where is …?.
Championing Evidence-Based Care in Patients With Acute Low Back Pain
My PAH Patient.
Primary and acute care to reduce morbidity and pain
Contribution of Vaccines to Life-Course Event-Free Health
Community Benefit Activities
Shared-Decision Making in Dyslipidemia
Best Practices in Building HIV Care Networks
Presentation transcript:

Tools to Address Adherence Issues in Patients With SIHD

Tools to Address Adherence Issues in Patients With SIHD: Overview

CVD The Magnitude of the Problema,b

Case Study Presentation

Population Health Creating a Culture of Wellness

SIHD Guideline Recommendations Section 4

Medication-Related Hospital Readmissionsa-c

Barriers to Medication Adherence

Case Study 2 Months Postdischarge Follow-up

Duke Activity Status Index (DASI)a,b Measure of METs

Strategies to Improve Medication Adherence in SIHD

Strategies to Improve Medication Adherence in SIHD (cont)

Improving Medication Adherence in SIHD

Oral Communication

Teach-Back Method

Case Study 6-Month Follow-Up

Patient as a Partner for Improved Outcomes in CVD

Conclusions

Abbreviations

Abbreviations (cont)

References

References (cont)

References (cont)

References (cont)